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Abstract
Misidentification delusions are false, fixed beliefs that assign an incorrect identity to a previously
familiar or unfamiliar person or place. Such delusions are common in several neuropsychiatric
disorders and place a particular burden on individuals with Major Neurocognitive Disorder and
their caregivers. No standard pharmacologic or non-pharmacologic treatment approaches have
been shown to be consistently effective in addressing this problem. We describe two caregivercare recipient dyads in which an innovative non-pharmacologic, digital intervention reduced
delusional misidentification, improved care recipient behavior, and decreased caregiver burden.

Background
Delusional Misidentification (DM) is among the most disruptive and recalcitrant behavioral
symptoms encountered in the care of persons with Major Neurocognitive Disorders (MaND).
More disruptive than simple loss of recognition, delusional beliefs in a caregiver-care recipient
dyad can seriously exacerbate caregiver burden while undermining the effectiveness and safety
of care.1
There is no specific diagnostic code for DM in the DSM-5, but clinically significant delusions in
a person with dementia justify the label of MaND “with behavioral disturbance”.2 Several
syndromes of DM occur in the context of MaND:
• In Capgras syndrome, a familiar person is incorrectly identified as an imposter.
• In reduplicative paramnesia, a familiar person or place exists in multiple, different
versions.
• In mirror self-misidentification, one’s reflection is experienced as a separate person.
• In Fregoli syndrome, a stranger is mistakenly identified as a disguised familiar
person.
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Prevalence estimates of DM vary widely, between 5% and 82%.3 The most common types are
Capgras syndrome and reduplicative paramnesia. DM may be especially common in Dementia
with Lewy Bodies, Vascular Dementia, and Alzheimer’s disease.2 When DM is present, affected
individuals and their caregivers must manage, often unsuccessfully, the challenging
consequences of a disrupted alliance. These can range from uncooperativeness and even
aggressive resistance to inappropriate familiarity.1 When DM develops within a caregiving dyad,
the care of an affected person becomes enormously more complicated.
The pathophysiology of DM syndromes may involve an interactive effect of lesions affecting the
fusiform gyrus, which mediates facial recognition; the perirhinal cortex and right hemisphere,
which mediate familiarity; and the frontal lobes, which test reality.4 Neurologically, DM appears
like a “disconnection syndrome” in which the links between recognition, emotional response,
and reality testing go awry.
No medication or non-pharmacologic intervention has been shown to be effective in consistently
reducing DM. However, evidence supports the effectiveness of non-pharmacologic approaches
such as reminiscence therapy, music therapy, validation, and simulated presence in mitigating
the severity of various non-cognitive symptoms associated with dementia.5 Digital interventions
are emerging as an effective means for delivering care. Research has shown successful reduction
of non-cognitive symptoms in people with MaND by means of personalized digital interventions
delivered in a formal care setting.6 For caregiver-recipient dyads living at home, too,
personalized digital interventions have proven successful in reducing non-cognitive symptoms of
MaND, facilitating positive and meaningful engagement, and providing overall caregiver support
reduced burden.7–9
We report here the successful treatment of DM in two caregiver-recipient dyads using a digital
tool that was modified to achieve two objectives important in the non-pharmacologic care of
people with MaND and DM: (1) Induce a positive affective state through reminiscence therapy
and curated, personalized music; and (2) reinforce recognition memory through spaced repetition
and consistency of visual cues linked with positive reminiscence, as is used in cognitive
rehabilitation approaches, thereby improving feelings of familiarity and enhancing a positive
emotional response towards the caregiver.

Case Presentations
Case Vignette – Dyad #1
Mr. X, a 78-year-old, married, non-Hispanic White male, was residing at home with his wife and
grandson at the time of referral to a Memory Disorders Clinic (MDC) for evaluation of an
episode of disorientation. His wife described his year-long history of cognitive and behavioral
symptoms including memory impairment, disorientation to date and location, restlessness and
pacing, and suspected hallucinations. His activities of daily living were partially dependent, and
he needed assistance with his instrumental activities of daily living. His Mini-Mental State
Examination10 score was 20/30 at initial cognitive assessment. Mr. X’s mood was euthymic. His
medical history was notable for vascular risk factors: previous myocardial infarction, adult-onset
diabetes mellitus, hyperlipidemia, and hypertension. He denied alcohol use. Routine laboratory
study results were within normal ranges. Brain MRI showed mild to moderate parenchymal
volume loss with significant patchy areas of T2/FLAIR hyperintensity in the periventricular,
subcortical, and deep white matter. His presentation was consistent with a diagnosis of vascular
.
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major neurocognitive disorder. During the year after his initial referral, Mr. X’s behavioral
symptoms became very disruptive to continued home care. His sundowning and agitation
required intervention from law enforcement personnel. Behavioral interventions, supplemented
with quetiapine 50 mg at bedtime, failed to halt the increasingly frequent delusional belief that
his wife was an imposter. His DM lasted for hours at a time. His behavior, when delusional,
made it necessary for his wife to leave the home repeatedly. Multiple additional medication trials
including escitalopram up to 10 mg/d, donepezil up to 23 mg/d, buspirone up to 5 mg twice
daily, risperidone up to 0.25 mg three times daily, melatonin up to 10 mg at bedtime and
cannabidiol oil failed to affect his delusion or improve his behavior.
Case Vignette – Dyad #2
Mrs. Y, an 89-year-old, married, non-Hispanic White female, was residing in an independent
living community apartment with her husband at the time of her referral to the MDC. She
expressed a fear that she was losing her memory. Her husband reported that her memory decline
had become apparent two years earlier, after an episode of complete heart block which included
a 14-hour run of bradycardia with a pulse of 25 beats per minute, culminating in insertion of a
pacemaker. Mr. Y reported that his wife’s cognitive symptoms included forgetting names, losing
her train of thought, and trouble with “getting her words out.” She experienced anxiety, crying
spells, and had a history of depressive episodes. She reported “seeing” her deceased parents. Her
confusion regularly increased in the evenings. Her activities of daily living remained
independent. Her instrumental activities were partially intact, though bill-paying required
assistance. She routinely participated in a sitting exercise class. She scored 16/30 on the
Montreal Cognitive Assessment (MoCA)11 and 10/15 on the Geriatric Depression Scale.12 Mrs.
Y’s medical history included multiple falls, a right parietal subdural hematoma requiring
craniotomy, treated hypothyroidism, complete heart block treated with a pacemaker, diminished
auditory acuity, and nocturia which interrupted her sleep 4 to 5 times nightly. Her head CT scan
showed evidence of periventricular small vessel disease, a small lacunar infarct in the left basis
pontis, and a small chronic left cerebellar infarct. In her delusional thinking, Mrs. Y split her
husband into two separate men with the same name, one trustworthy and the other a “menace.”
Her psychiatrist had prescribed quetiapine 12.5 mg twice daily and mirtazapine 7.5 mg at
bedtime for her delusions, with limited benefit.

Treatment Procedure
Mr. X, Mrs. Y, and their caregiving spouses each gave written informed consent to participate in
an IRB-approved clinical trial testing a non-pharmacological intervention designed for the
treatment of DM. The intervention began with a two-week assessment of baseline functioning
and behavior. During this time, images of each person with MaND and their spouse were
collected with the goal of obtaining at least 50 photographs. These images were assessed for
familiarity (five point scale), valence of the emotional response (positive, neutral, negative), and
recognition using a facial recognition assessment developed for this study. Based on the results
of the initial assessment, a total of 35 images were selected for each dyad’s intervention
program. A personalized digital intervention using the selected images and individualized music
was created on the SimpleC Platform for each person with MaND and accessed via the
Companion application on an iPad tablet.

.
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During the study, three active phases alternated with three control phases. Each phase lasted for
two weeks except for the final control phase, which lasted four weeks. During the study’s active
phases, the dyad engaged with their personalized intervention. During the control phases, the
dyad engaged with neutral images such as landscapes. The intervention consisted of two daily
15-minute sessions during which the dyad viewed and reengaged with the digital therapeutic
programs. The investigators conducted weekly check-ins throughout the study and one week
after a final, four week control phase. Each dyad’s caregiving spouse kept a daily diary and
symptom log throughout the trial.
Investigator-administered outcome measurements were obtained using the Neuropsychiatric
Inventory (NPI),13 the Misidentification Delusion Questionnaire (MDQ),14 the Zarit Caregiver
Burden Scale, (Zarit),15 the Quality of Life in Alzheimer’s Disease Scales for both person with
MaND and their spouse (QoL-AD),16 as well as expectation & experience questionnaires
developed for this study.
Facial recognition for all collected images was assessed three times as described above. The
procedure also included intermediate assessments of some images, at the end of each active and
control phase during the intervention to help engage deeper processing for better retention.17

Outcomes
Dyad #1
Mr. X showed improvements in neuropsychiatric symptoms (NPI) and quality of life over the
intervention period (Table 1). Specific NPI improvements were noted for symptoms of delusion
(drop from 9 to 1), hallucination (drop from 8 to 3), and agitation (drop from 6 to 2) through a
reduction in frequency, severity, and stressfulness of the symptom.
The MDQ also improved as well. The change reflected improved home recognition. The MDQ
did not capture wife recognition, but the diary did. At the end of the intervention, Mr. X agreed
that the intervention had helped him to be more connected, that he will know others better, and
others will know him better. He wanted to keep the intervention, saying “it is something very
nice” and “good for you.” At the end of the one month final control phase - without the
intervention - Mr. X did not mention these benefits.
Table 1: Standard Measures for Dyad #1
Measure
Session 1
Session 9
(Baseline)
(End of
intervention)
Lower scores are better
NPI Total (10 items)
55
44
NPI Stress (10 items)
14
12
MDQ
2
0
Zarit
26
38
Higher scores are better
QoL-AD – CR
32
39
QoL-AD – CG
28
23

Session 10
(End of final control
phase)

Max

60
19
1
37

120
50
11
88

37
22

52
52

In the experience questionnaire, Mrs. X reported that the intervention helped her husband to
recognize her more often, stating that he “became more affectionate” after using it. She liked the
.
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“time spent together reminiscing” with “nothing distracting our attention.” She reported that she
was “thrilled that he was more passionate,” and that it “stimulated conversation.” Mrs. X
reported more overall caregiver stress as measured by the Zarit and QoL-AD, but less stress
related to the neuropsychiatric symptoms as measured by the NPI. The caregiver’s diary
documented the decreasing frequency of DM over the course of the study.
Here are instances of non-recognition quoted from the diary to illustrate how DM manifested
itself in the life of Mr. and Mrs. X.
• Looking at pictures. Didn’t recognize me in several.
• Entering the mall, he told me “[Mrs. X] and I did this lots of times” – I just said
“really.”
• Getting ready to go to a birthday party gathering. [Mr. X] asked, “Where is [Mrs.
X?]”
• Watching TV, jumped up (where’s [Mrs. X]), left the room, went upstairs. Came
back, knew me and was fine. She had been with our daughter.
• Where’s [Mrs. X]? I asked, “what does she look like?” He answered, “I don’t know
what you’re talking about.”
• He asked, “Where’s [Mrs. X]”? I asked if she was young or old. He answered,
“don’t know.” What does she look like – don’t know anything. That was it.
Dyad #2
Mrs. Y showed improvements in neuropsychiatric symptoms (NPI) and MDQ during the
intervention period (Table 2). Mr. Y exhibited reduced caregiver stress related to
neuropsychiatric symptoms (NPI) and stable caregiver burden as measured by Zarit and QoLAD.
Table 2: Standard Measures for Dyad #2
Measure
Session 1
(Baseline)
Lower scores are better
NPI Total (10 items)
NPI Stress (10 items)
MDQ
Zarit
Higher scores are better
QoL-AD – CR
QoL-AD – CG

Session 9
(End of
intervention)

Session 10
(End of final control
phase)

Max

22
12
4
19

16
6
1
20

14
10
2
23

120
50
11
88

34
33

24
33

39
30

52
52

Of particular interest is the improvement captured by the facial recognition assessment. At
baseline, Mrs. Y rated 84% of the images as very familiar and responded negatively to 8% of the
images and neutrally to 10% of them. At the end of the intervention period, ratings increased to
100% familiarity and 100% positive valence. Familiarity remained high at the end of the final
control phase, with only a slight decrease in emotional valence.
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In the experience questionnaire, the caregiver Mr. Y noted “improved closeness when using
pictures and music,” and an overall more positive feeling. He stated that the intervention helped
his wife recognize him more often and more quickly. These benefits were more prominent at the
end of the intervention than the final one-month control phase without intervention. Mr. Y noted
that the intervention enhanced their relationship and helped him enjoy life with his wife.
Here are instances of non-recognition quoted from the diary to illustrate how DM manifested
itself in the life of Mr. and Mrs. Y.
• A very good day. Greeted each other with a kiss this morning. Daughter came over
in the morning to help organize [Mrs. Y’s] closest. Very pleasant visit. Normal
afternoon nap for [Mrs. Y], and then dinner with friends in dining room. Short
episode of confusion this morning.
• [Mrs. Y] was in MI [misidentification] mode much of the day. I was seen as a good
friend. She had an hour or so with mental confusion. I got frustrated trying to
straighten her out and she got angry. We kissed and made up before bedtime.
• Typical MI questions: How long have you lived here? Can I have a ride to church in
the morning? I am a good friend all day, including kissing good night as she went
to her room.
• [Mrs. Y] seemed to be in a non-MI mode this am. Sometimes hard to tell as life goes
on normally a lot of the time and I only discover later I was just a friend.

Discussion
The development of DM frequently interferes with care during the course of MaND. Borsje and
colleagues report DM as one of the most common neuropsychiatric symptoms in communitydwelling persons with dementia.18 Misidentification of a caregiver sets the stage for disruptive
and even dangerous consequences. An adult approached by a presumed imposter is unlikely to
cooperate with personal care such as bathing, toileting, or dressing. Confusion, modesty, fear, or
anger can lead a person with dementia to reject care, argue, flee, or even attack. The relationship
between DM and aggressive behavior in persons with major neurocognitive disorder has been
well-described.1,19 No medication reliably improves recognition, and no behavioral intervention
has previously been shown to improve or correct recognition of a spouse.
Overall, participation in the non-pharmacologic intervention described here was associated with
improved recognition. MDQ scores were reduced for both care recipients. Some DM persisted
for both care recipients. The MDQ’s apparent underestimation in care recipient 1 reinforced our
view that valid measurement of DM change is best captured by using multiple measures: MDQ,
NPI, as well as daily diary to capture the extent and manifestations of DM in daily life provided
cues to potential triggers. Care recipient 1 responded to the personalized non-pharmacological
intervention. The twice-daily review of images was associated with specific and nonspecific
benefits. Not only was recognition of his caregiving wife improved, but in addition he improved
on symptoms of delusion, hallucination, and agitation in frequency and severity. Furthermore,
his wife’s caregiving burden was reduced as measured by the NPI’s stress associated with
symptoms. Care recipient 2 also responded well, as seen by the change in emotional response to
facial recognition assessment.

.
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We believe that this intervention succeeded in helping our two care dyads significantly by
strengthening the relationship between memory and its associated affect. By repeatedly
presenting images of familiar faces with music for positive reminiscence, the intervention
enhances the connection between the faces and a positive emotional response. This may lead to
less suspicion and fewer negative emotions when interacting with the individuals. Technological
innovations such as the one studied may have a significant role in enhancing a sense of comfort
and familiarity in persons with dementia.
Finally, this intervention introduces a pleasant interaction into the daily life of care recipient and
caregiver, one which does not involve conflict or control struggles. With progression of
cognitive impairment, increasing caregiver time is spent coaxing a care recipient through
activities of daily living and this intervention incorporates the sharing of pleasant experiences
and gentle encouragement. Further study of this intervention is in progress.

Take-Home Message
Many persons living with dementia and the families caring for them strive to continue homebased care for as long as that remains tolerable and safe. DM is an important barrier to continued
care at home because it undermines the trust and comfort required for successful delivery of
personal care and collaborative interactions with a caregiver. In the context of DM, the person
with MaND’s effort to resist care, to flee or even to attack a caregiver becomes understandable
and, from his or her standpoint, justifiable. Although response of DM to medications is often
disappointing, the success of this simple, digital, non-pharmacologic intervention holds out hope
for effectively managing the delusions that would otherwise shorten the duration of successful
home-based care.
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